Ticker	Volume	Price	Price Delta
DJIA	15,387.60	+52.30	0.34%
S&P 500	1,669.16	+2.87	0.17%
Nasdaq	3,502.12	+5.69	0.16%

Ticker

Volume

Price

Price Delta

DJIA

15,387.60

+52.30

0.34%

S&P 500

1,669.16

+2.87

0.17%

Nasdaq

3,502.12

+5.69

0.16%

Ticker	Volume	Price	Price Delta
STOXX 50	2,821.99	+0.34	0.01%
FTSE 100	6,790.43	-13.44	-0.20%
DAX	8,458.23	-13.97	-0.16%

Ticker

Volume

Price

Price Delta

STOXX 50

2,821.99

+0.34

0.01%

FTSE 100

6,790.43

-13.44

-0.20%

DAX

8,458.23

-13.97

-0.16%

Ticker	Volume	Price	Price Delta
Nikkei	15,627.30	+246.24	1.60%
Hang Seng	23,238.80	-127.53	-0.55%
S&P/ASX 200	5,165.37	-14.69	-0.28%

Ticker

Volume

Price

Price Delta

Nikkei

15,627.30

+246.24

1.60%

Hang Seng

23,238.80

-127.53

-0.55%

S&P/ASX 200

5,165.37

-14.69

-0.28%

Humana, HCA Most at Risk in Deficit Deal, Study Says (Video)

2012-09-24T16:24:41Z

Matt Barry, a health-care analyst with Bloomberg Government, discusses how a deficit reduction deal involving Medicare or Medicaid may affect the five largest publicly traded hospitals and health-insurance companies.

Barry details his findings in a Bloomberg Government Study, “Exposure of Hospitals and Health Plans to a Potential Deficit Deal.” (Source: Bloomberg)

Running time 03:05

Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.